CVE-2020-7355

Public Exploit
Rapid7 Metasploit Pro Stored XSS in 'notes' field

Description

Cross-site Scripting (XSS) vulnerability in the 'notes' field of a discovered scan asset in Rapid7 Metasploit Pro allows an attacker with a specially-crafted network service of a scan target store an XSS sequence in the Metasploit Pro console, which will trigger when the operator views the record of that scanned host in the Metasploit Pro interface. This issue affects Rapid7 Metasploit Pro version 4.17.1-20200427 and prior versions, and is fixed in Metasploit Pro version 4.17.1-20200514. See also CVE-2020-7354, which describes a similar issue, but involving the generated 'host' field of a discovered scan asset.

Remediation

Solution:

  • Update to Metasploit Pro version 4.17.1-20200514 to fix this issue.

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.43%
Vendor Advisory rapid7.com
Affected: Rapid7 Metasploit Pro
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2020-7355?
CVE-2020-7355 has been scored as a medium severity vulnerability.
How to fix CVE-2020-7355?
To fix CVE-2020-7355: Update to Metasploit Pro version 4.17.1-20200514 to fix this issue.
Is CVE-2020-7355 being actively exploited in the wild?
It is possible that CVE-2020-7355 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-7355?
CVE-2020-7355 affects Rapid7 Metasploit Pro.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.